Literature DB >> 9191348

A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production.

S G Ward1, R V Parry, J Matthews, L O'Neill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191348     DOI: 10.1042/bst025304s

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  8 in total

1.  Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion.

Authors:  A Zaheer; M A Yorek; R Lim
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

2.  Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.

Authors:  T ten Hove; B van den Blink; I Pronk; P Drillenburg; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Negative regulation of interleukin-2 and p38 mitogen-activated protein kinase during T-cell activation by the adaptor ALX.

Authors:  Claire E Perchonock; Melissa C Fernando; William J Quinn; Chau T Nguyen; Jing Sun; Michael J Shapiro; Virginia Smith Shapiro
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

4.  Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.

Authors:  S Weg-Remers; H Ponta; P Herrlich; H König
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

5.  Alternative ZAP70-p38 signals prime a classical p38 pathway through LAT and SOS to support regulatory T cell differentiation.

Authors:  Jesse E Jun; Kayla R Kulhanek; Hang Chen; Arup Chakraborty; Jeroen P Roose
Journal:  Sci Signal       Date:  2019-07-23       Impact factor: 8.192

6.  Cholesterol induces pancreatic β cell apoptosis through oxidative stress pathway.

Authors:  Xiuli Lu; Jianli Liu; Fangfang Hou; Zhenqing Liu; Xiangyu Cao; Hisao Seo; Bing Gao
Journal:  Cell Stress Chaperones       Date:  2011-04-07       Impact factor: 3.667

7.  Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.

Authors:  James W Antoon; Melyssa R Bratton; Lori M Guillot; Scott Wadsworth; Virgilio A Salvo; Steven Elliott; John A McLachlan; Matthew E Burow
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

8.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Authors:  Ludmila Jirmanova; Dandapantula N Sarma; Dragana Jankovic; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.